BTG1 mutation correlates with inferior prognosis in diffuse large B-cell lymphoma
Last Updated: Friday, July 17, 2026
According to data from a recent analysis of tissue samples from patients with DLBCL, the BTG1 mutation may be a promising prognostic predictor for the disease. BTG1 mutation was associated with adverse clinical features and inferior overall survival.
